Review




Structured Review

STEMCELL Technologies Inc epscm with or without ifnγ stimulation
Epscm With Or Without Ifnγ Stimulation, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/epscm with or without ifnγ stimulation/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
epscm with or without ifnγ stimulation - by Bioz Stars, 2026-02
90/100 stars

Images



Similar Products

90
Thermo Fisher epscm (dmem/f12
Epscm (Dmem/F12, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/epscm (dmem/f12/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
epscm (dmem/f12 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Thermo Fisher epscm—dmem/f12
Epscm—Dmem/F12, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/epscm—dmem/f12/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
epscm—dmem/f12 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc epscm with or without ifnγ stimulation
Epscm With Or Without Ifnγ Stimulation, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/epscm with or without ifnγ stimulation/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
epscm with or without ifnγ stimulation - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
PeproTech derived from ec with or without additional stimulation of 100 ng/ml ifnγ
Effect of endothelial Pfn1 depletion on immunomodulatory cytokine/chemokine secretion in vitro and in vivo. A and B) Relative abundance of indicated cytokines/chemokines circulating in the serum of Pfn1 WT vs Pfn1 EC-KO mice collected either 8–10 days (mid-stage, panel A) or 15–18 days (late-stage, panel B) after the last TMX administration. Data representative of at least three separate litters with “ n ” representing the total number of mice in each group pooled from different litters. C and D) Real-time quantitative RT-PCR ( panel C ; n = 3 experiments) and immunoblot ( panel D ) validations of Pfn1 depletion in Ad-Cre–infected EC with Ad-GFP–infected cells serving as control (18S RT-PCR and GAPDH blots serve as the housekeeping gene control and loading control for RT-PCR and immunoblot experiments, respectively). E) Relative abundance of indicated cytokines/chemokines in the CM of Ad-Cre–infected EC relative to Ad-GFP–infected control cells (data represent the average fold change based on three independent experiments). F) Relative abundance of IL6 mRNA expression in circulating primary F4/80+ cells isolated from mice with the indicated genotypes ( n = 6 mice/group pooled from two separate litters). G) Relative abundance of IL6 mRNA expression in macrophages differentiated from primary BMDM and exposed to the CM of Ad-Cre– vs Ad-GFP–infected EC, either in the absence or in the presence of <t>IFNγ</t> <t>stimulation</t> (data summarized from five independent experiments). * P < 0.05 and ** P < 0.01.
Derived From Ec With Or Without Additional Stimulation Of 100 Ng/Ml Ifnγ, supplied by PeproTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/derived from ec with or without additional stimulation of 100 ng/ml ifnγ/product/PeproTech
Average 90 stars, based on 1 article reviews
derived from ec with or without additional stimulation of 100 ng/ml ifnγ - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Thermo Fisher epscm: dmem/f12
Effect of endothelial Pfn1 depletion on immunomodulatory cytokine/chemokine secretion in vitro and in vivo. A and B) Relative abundance of indicated cytokines/chemokines circulating in the serum of Pfn1 WT vs Pfn1 EC-KO mice collected either 8–10 days (mid-stage, panel A) or 15–18 days (late-stage, panel B) after the last TMX administration. Data representative of at least three separate litters with “ n ” representing the total number of mice in each group pooled from different litters. C and D) Real-time quantitative RT-PCR ( panel C ; n = 3 experiments) and immunoblot ( panel D ) validations of Pfn1 depletion in Ad-Cre–infected EC with Ad-GFP–infected cells serving as control (18S RT-PCR and GAPDH blots serve as the housekeeping gene control and loading control for RT-PCR and immunoblot experiments, respectively). E) Relative abundance of indicated cytokines/chemokines in the CM of Ad-Cre–infected EC relative to Ad-GFP–infected control cells (data represent the average fold change based on three independent experiments). F) Relative abundance of IL6 mRNA expression in circulating primary F4/80+ cells isolated from mice with the indicated genotypes ( n = 6 mice/group pooled from two separate litters). G) Relative abundance of IL6 mRNA expression in macrophages differentiated from primary BMDM and exposed to the CM of Ad-Cre– vs Ad-GFP–infected EC, either in the absence or in the presence of <t>IFNγ</t> <t>stimulation</t> (data summarized from five independent experiments). * P < 0.05 and ** P < 0.01.
Epscm: Dmem/F12, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/epscm: dmem/f12/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
epscm: dmem/f12 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


Effect of endothelial Pfn1 depletion on immunomodulatory cytokine/chemokine secretion in vitro and in vivo. A and B) Relative abundance of indicated cytokines/chemokines circulating in the serum of Pfn1 WT vs Pfn1 EC-KO mice collected either 8–10 days (mid-stage, panel A) or 15–18 days (late-stage, panel B) after the last TMX administration. Data representative of at least three separate litters with “ n ” representing the total number of mice in each group pooled from different litters. C and D) Real-time quantitative RT-PCR ( panel C ; n = 3 experiments) and immunoblot ( panel D ) validations of Pfn1 depletion in Ad-Cre–infected EC with Ad-GFP–infected cells serving as control (18S RT-PCR and GAPDH blots serve as the housekeeping gene control and loading control for RT-PCR and immunoblot experiments, respectively). E) Relative abundance of indicated cytokines/chemokines in the CM of Ad-Cre–infected EC relative to Ad-GFP–infected control cells (data represent the average fold change based on three independent experiments). F) Relative abundance of IL6 mRNA expression in circulating primary F4/80+ cells isolated from mice with the indicated genotypes ( n = 6 mice/group pooled from two separate litters). G) Relative abundance of IL6 mRNA expression in macrophages differentiated from primary BMDM and exposed to the CM of Ad-Cre– vs Ad-GFP–infected EC, either in the absence or in the presence of IFNγ stimulation (data summarized from five independent experiments). * P < 0.05 and ** P < 0.01.

Journal: PNAS Nexus

Article Title: Vascular endothelial cell-specific disruption of the profilin1 gene leads to severe multiorgan pathology and inflammation causing mortality

doi: 10.1093/pnasnexus/pgad305

Figure Lengend Snippet: Effect of endothelial Pfn1 depletion on immunomodulatory cytokine/chemokine secretion in vitro and in vivo. A and B) Relative abundance of indicated cytokines/chemokines circulating in the serum of Pfn1 WT vs Pfn1 EC-KO mice collected either 8–10 days (mid-stage, panel A) or 15–18 days (late-stage, panel B) after the last TMX administration. Data representative of at least three separate litters with “ n ” representing the total number of mice in each group pooled from different litters. C and D) Real-time quantitative RT-PCR ( panel C ; n = 3 experiments) and immunoblot ( panel D ) validations of Pfn1 depletion in Ad-Cre–infected EC with Ad-GFP–infected cells serving as control (18S RT-PCR and GAPDH blots serve as the housekeeping gene control and loading control for RT-PCR and immunoblot experiments, respectively). E) Relative abundance of indicated cytokines/chemokines in the CM of Ad-Cre–infected EC relative to Ad-GFP–infected control cells (data represent the average fold change based on three independent experiments). F) Relative abundance of IL6 mRNA expression in circulating primary F4/80+ cells isolated from mice with the indicated genotypes ( n = 6 mice/group pooled from two separate litters). G) Relative abundance of IL6 mRNA expression in macrophages differentiated from primary BMDM and exposed to the CM of Ad-Cre– vs Ad-GFP–infected EC, either in the absence or in the presence of IFNγ stimulation (data summarized from five independent experiments). * P < 0.05 and ** P < 0.01.

Article Snippet: After 7 days, macrophages were replated and exposed to the CM derived from EC with or without additional stimulation of 100 ng/ml IFNγ (PeproTech, Cranbury NJ) for 24 h.

Techniques: In Vitro, In Vivo, Quantitative RT-PCR, Western Blot, Infection, Control, Reverse Transcription Polymerase Chain Reaction, Expressing, Isolation